MDL 29913 acts as selective antagonist of NK2 tachykinin receptor. It is used for the treatment of IBS.
CAT# | R1071 |
CAS | 135721-56-1 |
Synonyms/Alias | 1,4,7,10,13,16-Hexaazacyclooctadecane, Cyclic Peptide Deriv.; N-(2-Amino-4-methylpentyl)-N-methyl-L-leucyl-L-glutaminyl-L-tryptophyl-L-phenylalanylglycine (5→1)-Lactam |
M.F/Formula | C40H56N8O6 |
M.W/Mr. | 745 |
Sequence | QWFGLL(Modifications: Leu-5 - Leu-6 = Leu-CH2N(CH3)-Leu, Cyclized) |
Labeling Target | NK2 tachykinin receptor |
Appearance | White lyophilised solid |
Purity | >97% |
Activity | Antagonist |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Brief information of orexin peptide The past several years have provided important insights into the physiological significan ...
Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...
MEN 11270 (H-DArg-Arg-Pro-Hyp-Gly-Thi-c(Dab-Dtic-Oic-Arg)c(7γ-10α)) is a novel selective constrained peptide ant ...
Octreotide, a long-acting structural derivative of somatostatins, is a synthetic peptide analog of somatostatin with the same ...
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...